Orna Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Orna Therapeutics's estimated annual revenue is currently $29.1M per year.
- Orna Therapeutics's estimated revenue per employee is $193,750
- Orna Therapeutics's total funding is $100M.
Employee Data
- Orna Therapeutics has 150 Employees.
- Orna Therapeutics grew their employee count by -1% last year.
Orna Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Interim VP, Business Development | Reveal Email/Phone |
3 | Head Facilities & Operations | Reveal Email/Phone |
4 | Head People and Culture | Reveal Email/Phone |
5 | VP Regulatory Affairs | Reveal Email/Phone |
6 | Head Information Technology | Reveal Email/Phone |
7 | VP, Portfolio & Program Management | Reveal Email/Phone |
8 | Head Intellectual Property | Reveal Email/Phone |
9 | Director, Manufacturing Science and Technology | Reveal Email/Phone |
10 | Director, Enterprise Applications | Reveal Email/Phone |
Orna Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Orna Therapeutics?
Orna Therapeutics is a venture-backed, Cambridge-based startup creating a pipeline of circular RNA (oRNA) therapeutics based on technology originated at MIT. Our mission is to address diseases not accessible through existing technologies, bringing meaningful therapies to patients in need.
keywords:N/A
$100M
Total Funding
150
Number of Employees
$29.1M
Revenue (est)
-1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Orna Therapeutics News
US start-up Orna Therapeutics is looking at ways to use circular RNA technology to develop therapeutics for cancer, autoimmune diseases,...
Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA)...
CAMBRIDGE, Mass., Feb. 24, 2021 /PRNewswire/ -- Orna Therapeutics, a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA therapeutics (oRNAs), today announced the completion of its $80 million Series A financing. Founded on groundbreaking rese ...
Orna Therapeutics announced that it has received $80 million in series A round of funding co-led by returning investor MPM Capital, Taiho Ventures, LLC and F2 Capital Ltd on February 24, 2021. The transaction included participation from leading strategic investors Astellas Venture Management LLC ...
Orna Therapeutics, a Cambridge, Mass.-based biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA therapeutics (oRNAs), completed an $80m Series A financing. The round was co-led by MPM Capital, Taiho Ventures, and F2 Ventures, with participati ...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.5M | 150 | 7% | N/A |
#2 | $40.4M | 150 | 7% | N/A |
#3 | $29.1M | 150 | -3% | $53.8M |
#4 | $24.9M | 151 | -1% | N/A |
#5 | $37.7M | 151 | N/A | N/A |